1509 studies found for:    "Liver Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
"Liver Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Suspended PET/CT-Assessment of Liver Tumor Ablation
Conditions: Liver Tumor;   Liver Neoplasms
Interventions: Radiation: N-13 ammonia;   Device: PET/CT scanner
2 Recruiting Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
Conditions: Liver Neoplasms;   Hepatic Cancer;   Liver Cancer
Interventions: Procedure: Thermal Ablation;   Procedure: Standard External Beam Radiation Therapy
3 Recruiting Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma;   Liver Neoplasms;   Adenoma, Liver Cell;   Carcinoma, Hepatocellular;   Liver Neoplasms, Experimental
Interventions: Drug: TRC 105;   Drug: Sorafenib
4 Recruiting Follow-up Yttrium-90 Internal Pair Production PET/CT Imaging in Patients With Primary or Metastatic Liver Tumors as Compared With Brehmsstrahlung Imaging
Conditions: Liver Cancer;   Hepatic Tumors
Intervention: Device: PET/CT Scan
5 Recruiting Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Interventions: Drug: Trametinib;   Drug: Sorafenib
6 Recruiting Hepatocellular Cancer (HCC) Screening in Zhongshan City
Condition: Liver Neoplasms
Intervention: Biological: Biomarker testing and Ultrasonography
7 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Intervention: Drug: OMP-54F28 with Sorafenib
8 Completed Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
Condition: Liver Neoplasms
Intervention: Drug: perflutren lipid microspheres
9 Suspended Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation
Conditions: Liver Cancer;   Liver Tumor;   Hepatocellular Carcinoma;   Liver Carcinoma
Intervention:
10 Recruiting Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Conditions: Liver Cell Caricinoma;   Liver Cancer;   Hepatocellular Carcinoma;   Liver Neoplasms
Interventions: Drug: Tremelimumab;   Procedure: TACE;   Procedure: Radiofrequency Ablation (RFA)
11 Completed CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer
Conditions: Advanced Hepatocellular Carcinoma;   Liver Cancer;   Hepatic Cancer;   Liver Neoplasms
Interventions: Drug: CS-1008;   Drug: sorafenib
12 Completed Oxaliplatin in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: oxaliplatin;   Other: laboratory biomarker analysis
13 Withdrawn SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: lonafarnib;   Procedure: conventional surgery
14 Completed
Has Results
Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Biological: bevacizumab;   Drug: erlotinib hydrochloride
15 Completed Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer
Condition: Liver Neoplasms
Interventions: Device: Microwave ablation;   Device: Radiofrequency ablation
16 Completed Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
Conditions: Carcinoma, Hepatocellular;   Liver Neoplasms
Intervention: Device: yttrium Y 90 microspheres (TheraSphere®)
17 Withdrawn Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
Condition: Liver Neoplasms
Intervention: Drug: Temsirolimus 25mg and Pegylated liposomal doxorubicin 25mg/m2
18 Completed Chemotherapy in Treating Children With Liver Cancer
Condition: Liver Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Procedure: conventional surgery
19 Completed A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
Conditions: Liver Neoplasms;   Neoplasm Metastasis
Interventions: Procedure: Isolated hepatic portal and arterial perfusion;   Drug: Melphalan
20 Recruiting TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   Liver Neoplasm;   Primary Liver Cancer
Intervention: Device: TheraSphere

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years